Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | -23,989 | 73,787 | 70,451 | 56,311 | 47,061 |
| Operating Income | 23,989 | -73,787 | -70,451 | -56,311 | -47,061 |
| Other Income | 9,185 | 8,183 | 8,929 | 9,576 | 10,718 |
| Pre-tax Income | 33,174 | -65,604 | -61,522 | -46,735 | -36,343 |
| Income Tax | 170 | 108 | 139 | 98 | 136 |
| Net Income Continuous | 33,004 | -65,712 | -61,661 | -46,833 | -36,479 |
| Net Income | $33,004 | $-65,712 | $-61,661 | $-46,833 | $-36,479 |
| EPS Basic Total Ops | 0.62 | -1.12 | -1.07 | -0.82 | -0.65 |
| EPS Basic Continuous Ops | 0.63 | -1.12 | -1.07 | -0.82 | -0.65 |
| EPS Diluted Total Ops | 0.62 | -1.12 | -1.07 | -0.82 | -0.65 |
| EPS Diluted Continuous Ops | 0.63 | -1.12 | -1.07 | -0.82 | -0.65 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.37 | -0.36 | -0.27 | -0.22 |
| EBITDA(a) | $37,574 | $-76,722 | $-74,500 | $-61,234 | $-34,344 |